BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35045365)

  • 21. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.
    Sen S; Wang SY; Soulos PR; Frick KD; Long JB; Roberts KB; Yu JB; Evans SB; Chagpar AB; Gross CP
    J Natl Cancer Inst; 2014 Mar; 106(3):dju008. PubMed ID: 24598714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases.
    Ekpunobi IO; McClelland S
    Am J Clin Oncol; 2024 Jun; 47(6):289-290. PubMed ID: 38372269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancer.
    Hodges JC; Lotan Y; Boike TP; Benton R; Barrier A; Timmerman RD
    Am J Manag Care; 2012 May; 18(5):e186-93. PubMed ID: 22694113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study.
    Versteeg AL; Hes J; van der Velden JM; Eppinga W; Kasperts N; Verkooijen HM; van Vulpen M; Oner FC; Seravalli E; Verlaan JJ
    Acta Oncol; 2019 Feb; 58(2):251-256. PubMed ID: 30513233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis.
    Wu X; Uhlig J; Blasberg JD; Gettinger SN; Suh RD; Solomon SB; Kim HS
    J Vasc Interv Radiol; 2022 Aug; 33(8):964-971.e2. PubMed ID: 35490932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-utility of stereotactic radiation therapy
    Leung HWC; Chan ALF
    Oncotarget; 2017 Sep; 8(43):75568-75576. PubMed ID: 29088891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
    Qu XM; Chen Y; Zaric GS; Senan S; Olson RA; Harrow S; John-Baptiste A; Gaede S; Mulroy LA; Schellenberg D; Senthi S; Swaminath A; Kopek N; Liu M; Warner A; Rodrigues GB; Palma DA; Louie AV
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1176-1184. PubMed ID: 33309977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.
    Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
    Brachytherapy; 2015; 14(1):29-36. PubMed ID: 25443528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in Patterns of Conventional Versus Stereotactic Body Radiotherapy in the Treatment of Spine Metastasis in the United States.
    Kim E; McClelland S; Jaboin JJ; Attia A
    J Palliat Care; 2021 Apr; 36(2):130-134. PubMed ID: 33356987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
    Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases.
    Lester-Coll NH; Rutter CE; Bledsoe TJ; Goldberg SB; Decker RH; Yu JB
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):663-72. PubMed ID: 27055395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of treatment strategies for high risk prostate cancer.
    Kowalchuk RO; Kim H; Harmsen WS; Jeans EB; Morris LK; Mullikin TC; Miller RC; Wong WW; Vargas CE; Trifiletti DM; Phillips RM; Choo CR; Davis BJ; Beriwal S; Tendulkar RD; Stish BJ; Breen WG; Waddle MR
    Cancer; 2022 Nov; 128(21):3815-3823. PubMed ID: 36070558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ; Wee JO; Punglia RS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.